Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication

Simon A. Surguladze, Elvina M. Chu, Nicolette Marshall, Anthony Evans, Anantha P. P. Anilkumar, Clive Timehin, Colm McDonald, Christine Ecker, Mary L. Phillips, Anthony S. David

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

We employed two event-related functional magnetic resonance imaging tasks using the pictures of mild and intense facial emotions of fear or happiness. The sample comprised 16 chronic schizophrenia patients treated with risperidone long-acting injections (RLAI), 16 patients treated with conventional antipsychotic depots (CONV) and 16 healthy controls (HC). The HC and RLAI groups demonstrated greater activation in the left amygdala in response to intensively fearful faces, and in right cerebellum to intensively happy faces compared with CONV patients. The CONV group demonstrated under-activation in the right temporal pole in response to intensively happy faces (compared with HC) and over-activation in ventro-medial prefrontal cortex (VMPFC) in response to both intensively happy and fearful expressions, compared with HC and RLAI groups. Our results suggest that networks implicated in the allocation of attentional resources (VMPFC) and emotion processing (amygdala, cerebellum) are differentially affected in patients on CONV versus RLAI.
Original languageEnglish
Pages (from-to)722 - 733
Number of pages12
JournalJournal of Psychopharmacology
Volume25
Issue number6
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Dive into the research topics of 'Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication'. Together they form a unique fingerprint.

Cite this